BRPI0815092A2 - Moduladores duais de receptores 5-ht2a e d3 - Google Patents

Moduladores duais de receptores 5-ht2a e d3

Info

Publication number
BRPI0815092A2
BRPI0815092A2 BRPI0815092-3A2A BRPI0815092A BRPI0815092A2 BR PI0815092 A2 BRPI0815092 A2 BR PI0815092A2 BR PI0815092 A BRPI0815092 A BR PI0815092A BR PI0815092 A2 BRPI0815092 A2 BR PI0815092A2
Authority
BR
Brazil
Prior art keywords
ht2a
dual
receiver modulators
modulators
receiver
Prior art date
Application number
BRPI0815092-3A2A
Other languages
English (en)
Inventor
Luca Gobbi
Georg Jaeshke
Olivier Roche
Rosa Maria Rodrigues Sarmiento
Lucinda Steward
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0815092A2 publication Critical patent/BRPI0815092A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0815092-3A2A 2007-07-26 2008-07-17 Moduladores duais de receptores 5-ht2a e d3 BRPI0815092A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07113252 2007-07-26
PCT/EP2008/059356 WO2009013212A2 (en) 2007-07-26 2008-07-17 Dual modulators of 5-ht2a and d3 receptors

Publications (1)

Publication Number Publication Date
BRPI0815092A2 true BRPI0815092A2 (pt) 2015-02-03

Family

ID=40281888

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0815092-3A2A BRPI0815092A2 (pt) 2007-07-26 2008-07-17 Moduladores duais de receptores 5-ht2a e d3

Country Status (16)

Country Link
US (4) US20090029977A1 (pt)
EP (1) EP2183245B1 (pt)
JP (1) JP5502733B2 (pt)
KR (1) KR101169518B1 (pt)
CN (1) CN101778844B (pt)
AR (1) AR067662A1 (pt)
AU (1) AU2008280187B2 (pt)
BR (1) BRPI0815092A2 (pt)
CA (1) CA2694009A1 (pt)
CL (1) CL2008002162A1 (pt)
ES (1) ES2498673T3 (pt)
PE (1) PE20090892A1 (pt)
RU (1) RU2480466C2 (pt)
TW (1) TWI363623B (pt)
WO (1) WO2009013212A2 (pt)
ZA (1) ZA201000354B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2399447T3 (es) * 2006-02-17 2013-04-01 F. Hoffmann-La Roche Ag Derivados benzoil-piperidina como moduladores de 5HT2/D3
KR101329548B1 (ko) 2008-09-22 2013-11-18 에프. 호프만-라 로슈 아게 피페라진 ｄ3 및 5-ｈｔ2ａ 수용체 조절제
WO2010034656A1 (en) * 2008-09-23 2010-04-01 F. Hoffmann-La Roche Ag Isoxazolo[4,5]pyridin-3-yl-piperazin derivatives useful as modulatorsof dopamine d3 receptors
US8470828B2 (en) * 2010-07-06 2013-06-25 Hoffmann-La Roche Inc. Anellated pyridine compounds
US8877778B2 (en) * 2010-12-15 2014-11-04 Hoffmann-La Roche Inc. Benzofurane compounds
US8722683B2 (en) * 2011-02-17 2014-05-13 Hoffmann La-Roche Inc. Benzodioxole piperazine compounds
US8598357B2 (en) * 2011-03-03 2013-12-03 Hoffmann-La Roche Inc. Benzodioxole piperidine compounds
US8921397B2 (en) * 2011-05-04 2014-12-30 Hoffmann-La Roche Inc. Benzofurane-piperidine compounds
CN105367565B (zh) * 2014-08-20 2018-10-02 上海医药工业研究院 哌嗪(啶)环己基衍生物及其治疗精神神经疾病的应用
CN106518841B (zh) * 2015-09-15 2019-03-05 浙江京新药业股份有限公司 环己烷衍生物或其立体异构体或盐及其制备与应用
WO2017045599A1 (zh) * 2015-09-15 2017-03-23 浙江京新药业股份有限公司 环己烷衍生物或其立体异构体或盐及其制备与应用
JP7015092B2 (ja) 2016-07-28 2022-02-02 塩野義製薬株式会社 ドーパミンｄ３受容体拮抗作用を有する含窒素縮環化合物
JP7250405B2 (ja) * 2018-01-26 2023-04-03 塩野義製薬株式会社 ドーパミンｄ３受容体拮抗作用を有する環式化合物
JPWO2019146739A1 (ja) 2018-01-26 2021-01-07 塩野義製薬株式会社 ドーパミンｄ３受容体拮抗作用を有する縮環化合物
BR112022007238A2 (pt) 2019-10-29 2022-07-05 Shanghai Hansoh Biomedical Co Ltd Compostos modificadores derivados de anel de quatro membros, métodos para preparar os referidos compostos, composição e uso
US20230002364A1 (en) * 2019-11-05 2023-01-05 Shanghai Hansoh Biomedical Co., Ltd. Benzothiophene derivative regulator, preparation method therefor and use thereof
KR20230004662A (ko) * 2020-04-26 2023-01-06 지앙수 엔화 파마수티컬 컴퍼니 리미티드 1,5-디하이드로-2,4-벤조디아제핀-3-온 유도체 및 이의 응용
TW202302576A (zh) 2021-04-28 2023-01-16 大陸商上海翰森生物醫藥科技有限公司 含哌嗪多環類衍生物的鹽及晶型及其製備方法和應用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364866A (en) * 1989-05-19 1994-11-15 Hoechst-Roussel Pharmaceuticals, Inc. Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
US5776963A (en) * 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
DK60693D0 (da) * 1993-05-26 1993-05-26 Novo Nordisk As Kemiske forbindelser, deres fremstilling og anvendelse
WO1998034933A1 (en) 1997-02-07 1998-08-13 Hoechst Marion Roussel, Inc. (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents
PT1054885E (pt) * 1998-02-09 2007-10-03 Duphar Int Res Derivativos de benzisoxazole tendo uma actividade d4-antagonista
DE10010612A1 (de) * 2000-03-03 2001-09-27 Merck Patent Gmbh Verwendung von PDE V-Inhibitoren
DE60208157T2 (de) 2001-02-16 2006-08-10 Aventis Pharmaceuticals Inc. Heterocyclische substituierte carbonyl derivate und ihre verwendung als dopamin d3 rezeptor liganden
GB0117950D0 (en) 2001-02-16 2001-09-19 Aventis Pharma Inc Novel heterocyclic urea derivatives andd their use as dopamine D3 receptor ligands
GB0117577D0 (en) * 2001-02-16 2001-09-12 Aventis Pharm Prod Inc Novel heterocyclic substituted carbonyl derivatives and their use as dopamine D receptor ligands
IL157412A0 (en) 2001-02-16 2004-03-28 Aventis Pharmaceuticals Inc Av Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands
ES2399447T3 (es) * 2006-02-17 2013-04-01 F. Hoffmann-La Roche Ag Derivados benzoil-piperidina como moduladores de 5HT2/D3
US7795437B2 (en) * 2006-10-31 2010-09-14 Hoffmann-La Roche Inc. Ether derivatives
MX2010001195A (es) * 2007-08-09 2010-03-01 Hoffmann La Roche Derivados de benzoil-peperidina como moduladores dobles de los receptores 5-ht2a y d3.
KR101329548B1 (ko) * 2008-09-22 2013-11-18 에프. 호프만-라 로슈 아게 피페라진 ｄ3 및 5-ｈｔ2ａ 수용체 조절제
ES2643613T3 (es) * 2010-08-17 2017-11-23 The Procter & Gamble Company Detergentes para el lavado de vajillas a mano sostenibles y estables
US8877778B2 (en) * 2010-12-15 2014-11-04 Hoffmann-La Roche Inc. Benzofurane compounds

Also Published As

Publication number Publication date
PE20090892A1 (es) 2009-07-13
AR067662A1 (es) 2009-10-21
US20130165432A1 (en) 2013-06-27
TWI363623B (en) 2012-05-11
KR101169518B1 (ko) 2012-07-27
KR20100036384A (ko) 2010-04-07
JP2010534632A (ja) 2010-11-11
CN101778844B (zh) 2013-01-02
EP2183245A2 (en) 2010-05-12
AU2008280187B2 (en) 2013-05-16
EP2183245B1 (en) 2014-07-09
RU2480466C2 (ru) 2013-04-27
CN101778844A (zh) 2010-07-14
TW200911236A (en) 2009-03-16
US20090029977A1 (en) 2009-01-29
AU2008280187A1 (en) 2009-01-29
US8829029B2 (en) 2014-09-09
RU2010104631A (ru) 2011-09-10
WO2009013212A3 (en) 2009-06-11
US20140350051A1 (en) 2014-11-27
ZA201000354B (en) 2010-10-27
ES2498673T3 (es) 2014-09-25
JP5502733B2 (ja) 2014-05-28
US20120040972A1 (en) 2012-02-16
CA2694009A1 (en) 2009-01-29
WO2009013212A2 (en) 2009-01-29
CL2008002162A1 (es) 2009-05-29

Similar Documents

Publication Publication Date Title
BRPI0815092A2 (pt) Moduladores duais de receptores 5-ht2a e d3
CR10930A (es) Moduladores receptores nicotinicos de acetilcolina
BRPI0818380A2 (pt) Combinação de herbicida-protetor
BRPI0903496A2 (pt) Dispositivos de transmissão e de recepção.
BRPI0921327A2 (pt) Combinação de herbicida-protetor
BRPI0820978A2 (pt) Comunicação de conteúdo de alteração visual
BRPI0813653A2 (pt) Compostos de imidazotiazol moduladores de sirtuína
BRPI0918949A2 (pt) moduladores de receptores de 5-ht2a e piperazina d3
BRPI0813651A2 (pt) Compostos de tiazolopiridina moduladores de sirtuína
BRPI0815588A2 (pt) Compostos de poliorganossiloxano-poliuréia e/ou de poliorganossilo-xano-poliuretano
BRPI0908821A2 (pt) Transmissão hidrostática com divisão de potência
GB2452361B (en) Optical time domain refectometry
BRPI1016117A8 (pt) derivados de isoxazol-isoxazol e isoxazol-isotiazol.
ITMI20072422A1 (it) Ricevitore ottico
BRPI0921058A2 (pt) éteres alquilciclo-hexílicos de di-hidrotetra-azabenzoazulenos
BRPI0811115A2 (pt) Compostos de heteroarilamida pirimidona
DE602006012929D1 (de) Optischer Empfänger
BRPI0922728A2 (pt) combinação de herbicida-antídoto
BRPI0810195A2 (pt) Moduladores de gpbar1
EP2356761A4 (en) OPTICAL TRANSMITTER
FR2921207B1 (fr) Adaptateur de raccordement
BRPI0816154A2 (pt) Moduladores canabinóides de 5-vinilfenil-1-fenil-pirazol substituídos
DK2118388T3 (da) Byggeenhed
FI20075272A0 (fi) Vastaanotin ja vastaanottomenetelmä
BRPI0718127A2 (pt) Moduladores duais de derivados de éter dos receptores de 5-ht2a e d3

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law
B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)